Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial

The Lancet Respiratory Medicine

Volumn 8, Issue 1, 2020, Pages 54-64

  Walker, Natalie ^a   Parag, Varsha ^a   Verbiest, Marjolein ^b   Laking, George ^a   Laugesen, Murray ^c   Bullen, Christopher ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b TILBURG UNIVERSITY   (Netherlands)

^c UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE; NICOTINE PATCH;

ACCIDENTAL DEATH; ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; DRUG OVERDOSE; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MALE; NEW ZEALAND; NICOTINE REPLACEMENT THERAPY; PARALLEL DESIGN; PATIENT COMPLIANCE; PRAGMATIC TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SELF REPORT; SIDE EFFECT; SMOKING CESSATION; TOBACCO DEPENDENCE; VAPING; ELECTRONIC CIGARETTE; MIDDLE AGED; PROCEDURES;

ADULT; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; SELF REPORT; SMOKING CESSATION; TOBACCO USE CESSATION DEVICES; VAPING;

EID: 85076511020     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(19)30269-3     Document Type: Article

References (31)

1. St Helen, G, Havel, C, Dempsey, DA, Jacob, P III, Benowitz, NL, Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 111 (2016), 535–544.
2. Farsalinos, K, Romagna, G, Tsiapras, D, Kyrzopoulos, S, Voudris, V, Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19 000 consumers. Intern J Environ Res Public Health 11 (2014), 4356–4373.
3. Bullen, C, Howe, C, Laugesen, M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382 (2013), 1629–1637.
4. Caponnetto, P, Campagna, D, Cibella, F, et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One, 8, 2013, e66317.
5. Tseng, T-Y, Ostroff, J, Campo, A, et al. A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine Tob Res 18 (2016), 1937–1943.
6. Carpenter, M, Heckman, B, Wahlquist, A, et al. A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects. Cancer Epidemiol Biomarkers Prev 26 (2017), 1795–1803.
7. Masiero, M, Lucchiari, C, Mazzocco, K, et al. E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine Tob Res 21 (2019), 119–126.
8. Halpern, SD, Harhay, MO, Saulsgiver, K, Brophy, C, Troxel, AB, Volpp, KG, A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med 378 (2018), 2302–2310.
9. Hajek, P, Phillips-Waller, A, Przulj, D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 380 (2019), 629–637.
10. Wagener, T, Floyd, E, Stepanov, I, et al. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control 26 (2017), e23–e28.
11. Walker, N, Verbiest, M, Kurdziel, T, et al. The effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial. BMJ Open, 9, 2019, e023659.
12. Stead, L, Koilpillai, P, Fanshawe, T, Lancaster, T, Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev, 3, 2016, CD008286.
13. Ministry of Health. Annual update of key results 2015/16: New Zealand Health Survey. 2016, Ministry of Health, Wellington https://www.health.govt.nz/publication/annual-update-key-results-2015-16-new-zealand-health-survey. (Accessed 1 July 2019)
14. Health Promotion Agency. Data release: updated preliminary analysis on 2016 health and lifestyle survey electronic cigarette questions. 2017, Health Promotion Agency, Wellington https://www.hpa.org.nz/sites/default/files/2016%20HLS%20E-cig%20preliminary%20analysis%20for%20MoH%20%23723522.pdf. (Accessed 1 July 2019)
15. Przulj, D, McRobbie, H, The effect of sensorimotor replacement on smoking cessation and craving. Open Addiction J 5 (2012), 41–50.
16. Stead, LF, Perera, R, Bullen, C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 11, 2012, CD000146.
17. Statistics New Zealand. New Zealand Census 2013. 2013, Statistics New Zealand, Wellington http://archive.stats.govt.nz/Census/2013-census.aspx. (Accessed 1 July 2019)
18. Stead, L, Koilpillai, P, Lancaster, T, Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev, 12, 2015, CD009670.
19. Ministry of Health. Background and recommendations of the New Zealand guidelines for helping people to stop smoking. 2014, Ministry of Health, Wellington https://www.health.govt.nz/publication/new-zealand-guidelines-helping-people-stop-smoking. (Accessed 1 July 2019)
20. Lindson, N, Chepkin, SC, Ye, W, Fanshawe, TR, Bullen, C, Hartmann-Boyce, J, Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 4, 2019, CD013308.
21. Bullen, C, Knight-West, O, Issues in regulating e-cigarette clinical research. Clin Res Reg Affairs 32 (2015), 1–5.
22. Hajek, P, Goniewicz, ML, Phillips, A, Myers Smith, K, West, O, McRobbie, H, Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob Res 17 (2015), 175–179.
23. Heatherton, TF, Kozlowski, LT, Frecker, RC, Fagerström, KO, The Fagerström Test For Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86 (1991), 1119–1127.
24. West, R, Hajek, P, Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacol 177 (2004), 195–199.
25. West, R, Hajek, P, Stead, L, Stapleton, J, Outcome criteria in smoking cessation trials: proposal for a standard. Addiction 100 (2005), 299–303.
26. Walker, N, Howe, C, Bullen, C, et al. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial. Addiction 107 (2012), 1857–1867.
27. Blondal, T, Gudmundsson, LJ, Olafsdottir, I, Gustavsson, G, Westin, A, Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 318 (1999), 285–288.
28. Cropsey, K, Trent, L, Clark, C, Stevens, E, Lahti, A, Hendricks, P, How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine Tob Res 16 (2014), 1348–1355.
29. Hartmann-Boyce, J, McRobbie, H, Bullen, C, Begh, R, Stead, LF, Hajek, P, Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev, 9, 2016, CD010216.
30. Hughes, J, Shiffman, S, Callas, P, Zhang, J, A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 12 (2003), 21–27.
31. Cohen, G, Mehoudar, P, Carbonara, C, Wynne, C, Acute use of nicotine salt-based ENDS and combusted cigarettes [poster] Society for Nicotine and Tobacco Annual meeting. Baltimore MD, USA. https://cdn.ymaws.com/www.srnt.org/resource/resmgr/conferences/2018_Annual_Meeting/65388_SRNT_2018_Rapids_Abstr.pdf, 2018 (July 1, 2019).